Healthy adults
Conditions
Interventions
Take a single dose of 200mL of placebo beverage.
Take a single low dose of 200mL of test beverage.
Take a single high dose of 200mL of test beverage.
Sponsors
IMEQRD Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. 20 to 39 years old (at the time of submission of an informed consent document). 2. Healthy individuals (those who were judged to be healthy by the principal investigator). 3. Males. 4. BMI 18.5 to 24.9 kg/m2 5. Those who can stay overnight the day before coming to the hospital. 6. Smartphone users (who can input their own data into the electronic diary). 7. Those who do not intend to change or do not change everyday lifestyle habits during the study period. 8. Those who can provide a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who are currently receiving drug treatments for some kind of illness (except for the drugs that are taken as needed). 2. Those who have seen a doctor regularly. 3. Those who have severe symptoms of anemia. 4. Those who have a current or a past medical history of the following severe diseases: diabetes, circulatory disease, hepatic disease, renal disease, and cardiac disease. 5. Those who have a current or a past medical history of drug and food allergies. 6. Those who regularly have a habit of taking the following products: pharmaceutical products, quasi-pharmaceutical products, health-promoting foods (Food for Specified Health Use), health foods, and supplements, or those who have a plan to take products listed above during the study period. 7. Those who consume 60 or more grams of alcohol per day. 8. Those who have a smoking habit. 9. Those who are currently receiving treatment for drug abuse and addiction or those who have a past medical history of drug abuse and addiction. 10. Those who are currently participating in another clinical trial. 11. Those who met the key exclusion criteria after the informed consent form was submitted. 12. Those who were determined by the principal investigator or a sub-investigator to be unsuitable for participation in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory quotient and lipid oxidation | — |
Secondary
| Measure | Time frame |
|---|---|
| Energy consumption and carbohydrate oxidation | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed